LV Dysfunction

Explore clinical trials studying LV Dysfunction. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

LV Dysfunction trial results

Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

NCT06699056

Conditions: Arrhythmias, Cardiac, Atrial Enlargement, Atrial Remodeling, +43 more
Locations: Orange County Heart Institute Orange, California, United States

Peerbridge Health Pasadena, California, United States

Henry Ford Hospital Detroit, Michigan, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Recruiting

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

NCT06705023

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
Locations: National Scientific Medical Center Astana, Kazakhstan

View Trial Details

Enrolling by Invitation

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

NCT06763549

Conditions: Apnea, Apnea, Obstructive, Arrhythmias, Cardiac, +79 more
Locations: Peerbridge Health, Melbourne, Florida 32935 Melbourne, Florida, United States

View Trial Details

Not Yet Recruiting

Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension

NCT06405555

Conditions: Cardiovascular Diseases, Heart Diseases, Heart Failure, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Coronary Artery Bypass Grafts or Percutaneous Coronary Intervention for High Risk Patients

NCT05534698

Conditions: Cardiovascular Diseases, Heart Diseases, IHD, +3 more
Locations: Rigshospitalet, University of Copenhagen Copenhagen, Denmark

View Trial Details

Completed

Pediatric Ventricle Function Assessment Study

NCT06739057

Conditions: Cardiovascular Diseases, Heart Diseases, Hypertension, +10 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Completed

Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)

NCT00187291

Conditions: Cardiovascular Diseases, Heart Diseases, Ischemic Cardiomyopathy, +3 more
Locations: Not specified

View Trial Details

LV Dysfunction

LV Dysfunction trial results

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension

Coronary Artery Bypass Grafts or Percutaneous Coronary Intervention for High Risk Patients

Pediatric Ventricle Function Assessment Study

Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)

Related conditions